KLA (KLAC) Stock Sinks As Market Gains: Here's Why

KLA fell 2.8% to $161.74, underperforming the S&P 500’s 0.28% gain, and was down 9.55% over the past month. Ahead of its October 28, 2026 earnings report, consensus calls for quarterly EPS of $1.18 and revenue of $4.05 billion, up 34.09% and 26.09% year over year; full-year estimates are $5.44 per share and $17.88 billion in revenue. Consensus EPS estimates rose 0.43% over the past month and KLA has a Zacks Rank of #2 (Buy), while its forward P/E of 30.6 exceeds the industry average of 18.81.

Analysis

The selloff looks more like a valuation/positioning warning than new evidence of weakening fundamentals: the article cites no company-specific negative catalyst, while the modest estimate revision signal does little to independently validate the much stronger growth embedded in forecasts. With KLAC trading at a premium to the cited industry multiple, the asymmetry into October 28 is unfavorable for an unhedged pre-earnings long: a merely in-line outlook may not support the premium, while weaker inspection/metrology demand or a cautious outlook could trigger further multiple compression.

Second-order exposure runs through wafer-fab equipment budgets and advanced-node/advanced-packaging investment. A pause in customer capex could affect KLA and peers such as Applied Materials, Lam Research, and Onto Innovation, though product mixes differ; a KLA-specific share loss is not established here. Export controls or a shift in regional customer mix are additional risks to monitor, not facts established by this article.

The contrarian case is that the recent underperformance may have priced in a reset despite estimates still edging up. The key test is not headline EPS growth but guidance, order/backlog commentary, and evidence that demand is broadening rather than concentrated. Near term, earnings and guidance dominate; over 1–3 months, estimate revisions and peer capex commentary can validate or reverse the move. Over 6–18 months, sustained advanced-node and packaging investment would support structural demand, but is not enough by itself to justify today’s premium.

Key Decisions for Investors

• Avoid adding an unhedged KLAC position ahead of October 28; the valuation premium leaves limited room for an in-line result, while event volatility is difficult to price from the information provided.
• If maintaining existing exposure, consider reducing event risk or using a defined-risk hedge. Reassess after results: a constructive setup requires guidance and order/backlog commentary to support demand, not just reported EPS.
• Treat a post-earnings long as conditional: enter only if guidance and subsequent estimate revisions improve, and monitor performance against Applied Materials, Lam Research, and Onto Innovation to distinguish sector weakness from KLAC-specific underperformance.
• Falsify the cautious thesis if KLAC delivers guidance above expectations, broad-based demand commentary, and positive estimate revisions without losing relative strength; deepen caution if guidance or order commentary weakens or the premium valuation contracts further.